• Acid base balance abnormal • Acidosis • Anion gap abnormal • Anion gap increased • Blood alkalinisation therapy • Blood bicarbonate abnormal • Blood bicarbonate decreased • Blood gases abnormal • Blood lactic acid abnormal • Blood pH abnormal • Blood pH decreased • Carbon dioxide combining power abnormal • Carbon dioxide combining power decreased • Coma酸性•Kussmaul呼吸•代谢性酸中毒•PCO2异常•PCO2降低•尿液乳酸增加|
2来自EZVIZ实验室测试结果的数据,在以下标准条件下:AM = 1.5,25°C,1000W/m2,SMQ。数据是根据每天5分钟的使用获得的,包括相机检测的活动和自动触发的记录。根据阳光强度和其他环境因素,实际的充电效率可能更高或更低,而实际使用的实际使用时间也可能会改变摄像机活动频率和其他环境因素的频率。
赞助商应维护预先指定的MEDDRA首选术语列表。pts符合裁决的资格将使用ILD标准化的MedDra查询(SMQ)中的所有狭窄术语组成,使用最新的MEDDRA版本,每项临床研究,选定的PTS和急性呼吸衰竭和呼吸衰竭的PTS。此外,如果将新的PT添加到最新版本的MedDra的窄ILD SMQ中,并且该PT在较早的MedDra中存在于狭窄的ILD SMQ之外,则在有效的研究中使用的MEDDRA中存在,匹配该术语的案例也将发送以进行裁决。有时会建立第三方或委员会来进行裁决过程,以确保该判断过程的独立性和准确性。Below is the list of selected broad PTs (PT code is used to link it up instead of preferred terms): • Acute respiratory distress syndrome • Allergic eosinophilia • Granulomatous pneumonitis • Organizing pneumonia • Pulmonary sarcoidosis • Restrictive pulmonary disease • Rheumatoid lung, and Sarcoidosis Please note that this is actually so-called Customized MedDRA Queries (cmqs)发起人定义的工具/过程,以满足他们的研究药物安全分析需求。以下是一些差异的常见情况:在这里,我们我们使用CMQ进行ILD数据识别,但是CMQ通常由每个TA,化合物或研究基础定义为仅适用于赞助商的研究特定规则,并且在整个过程中,统计/编程团队需要与医疗/临床团队密切合作,并将其备份到现有的情况下(即恢复/comport)(即恢复/comport)(即恢复/comport)(即恢复/comport)。如果使用CMQ方法,则编程和临床审查/确认过程和时间表。Reconciliation between RAVE and third-party committee transfer After the process of collecting and characterizing ILD/ Pneumonia -related data, reconciliation work will be conducted to see if any discrepancies between EDC data and third party committee result, two categories ILD and potential ILD (the definition of potential ILD means PT in the search list AND (it is TEAE or happened in the post-treatment period but related as per investigator) will be summarized according对和解的结果将在CSR分析中介绍
SMQ是出于公认的Meddra用户社区的需求,以帮助识别和检索安全数据。原始的Meddra特殊搜索类别(SSC)是出于类似目的而用于类似目的的,但是经过数年的使用,生物制药社区(监管机构和行业)得出结论,这些工具没有充分满足需求。在响应中,MEDDRA维护和支持服务组织(MSSO)于2002年初开始开发MEDDRA分析组(MAGS)。mags被定义为从MEDDRA层次结构的任何级别(通常是LLT)以及与MAG名称定义的医疗状况或感兴趣的领域相关的任何级别的术语集合,包括符号,症状,症状,身体发现,实验室和其他物理学测试数据以及与医疗状况相关的情况或与医疗状况相关的领域。
SMQ是出于公认的Meddra用户社区的需求,以帮助识别和检索安全数据。原始的Meddra特殊搜索类别(SSC)是出于类似目的而用于类似目的的,但是经过数年的使用,生物制药社区(监管机构和行业)得出结论,这些工具没有充分满足需求。在响应中,MEDDRA维护和支持服务组织(MSSO)于2002年初开始开发MEDDRA分析组(MAGS)。mags被定义为从MEDDRA层次结构的任何级别(通常是LLT)以及与MAG名称定义的医疗状况或感兴趣的领域相关的任何级别的术语集合,包括符号,症状,症状,身体发现,实验室和其他物理学测试数据以及与医疗状况相关的情况或与医疗状况相关的领域。
AD26腺病毒类型26 AE不良事件AR不良反应AESI不良事件特殊关注的事件ARDS急性呼吸窘迫综合征CBRN CBRN化学,生物学,放射学或CDC疾病控制和预防CMC CMC化学,制造和控制CT Computed Compograch Compograch Compograch Compograch Compogration ct Computed Ecmo ecmo efforeal Encorting Intrulage Intry Intrulage Intruliation Full yefter Intrulage Fulter Inture Fulter Inture Fulter Inture Fulta Intuperation Fusa Aa aa yaa Aa aaa FD&C Federal Food, Drug, and Cosmetic Act hACE2 human angiotensin converting enzyme 2 HHS Health and Human Services LMP last menstrual period MAAE medically attended adverse event MERS-CoV Middle Eastern respiratory syndrome MedDRA Medical Dictionary for Regulatory Activities MRU Medical Resource Utilization PT preferred term RT-PCR reverse transcription-polymerase chain reaction SAE serious adverse event SARS-CoV-2 severe急性呼吸综合征冠状病毒2 SMQ标准MEDDRA查询SAP统计分析计划VAERS疫苗不良事件报告系统VE疫苗疗效VP病毒颗粒VRBPAC VRBPAC疫苗和相关生物学产品咨询委员会
AE adverse event ARI acute respiratory illness BLA Biologics License Application CDC Centers for Disease Control and Prevention CI confidence interval COPD chronic obstructive pulmonary disease COVID-19 coronavirus disease 2019 eDiary electronic diary ERD enhanced respiratory disease FDA US Food and Drug Administration FI-RSV formalin-inactivated RSV GBS Guillain-Barré Syndrome LB lower bound LRTI lower respiratory tract infection LRTI-RSV RSV-associated lower respiratory tract illness MedDRA Medical Dictionary for Regulatory Activities MFS Miller Fisher syndrome NAAT nucleic acid amplification test NDCMC newly diagnosed chronic medical condition PASS post-authorization safety study PCR polymerase chain reaction preF prefusion F protein PT MedDRA preferred term PVP pharmacovigilance plan RSV呼吸综合病毒RT-PCR逆转录酶聚合酶链反应反应SAE严重不良事件SIIV季节性灭活流感疫苗SLRTI-RSV严重的RSV相关的RSV相关的下呼吸道相关的下呼吸道疾病,
Abbreviation Definition AE adverse event AESI adverse events of special interest BLA Biologics License Application BMI body mass index CDC US Centers for Disease Control CMC Chemistry, Manufacturing, and Control CoV Coronavirus 2019-nCoV 2019 novel Coronavirus COVID-19 Coronavirus Disease 2019 DART developmental and reproductive toxicity ELISpot enzyme-linked immunospot EUA Emergency Use Authorization FDA (US) Food and Drug Administration FIH first-in-human GMC geometric mean concentration GMFR geometric mean fold-rise GMT geometric mean titer HBV hepatitis B virus HCV hepatitis C virus HIV human immunodeficiency virus IFN γ interferon gamma IgG immunoglobulin G IL-2 interleukin 2 IL-4 interleukin 4 IM intramuscular(ly) IRR illness rate ratio LLN lower limit of normal LNP lipid nanoparticle MedDRA Medical Dictional for Regulatory Activities MERS Middle East respiratory syndrome modRNA nucleoside-modified RNA NAAT nucleic acid amplification test NHP nonhuman primate P2 S P2 mutant PBMC peripheral blood mononuclear cell PCR polymerase chain reaction PK药代动力学PT首选术语RBD受体结合结构域RNA RNA核糖酸RNA-LNP RNA RNA脂质纳米颗粒SAE SAE严重不良事件SARS严重急性呼吸综合症SARS-COV-2 SARS-COV-2 SARS COTORONAVIRUS-CORONAVIRUS-2;引起covid-19的病毒S尖峰糖蛋白SMQ标准化MEDDRA查询SOC系统器官类Th1 T辅助细胞类型1 TH2 T辅助细胞类型2美国美国USP美国Pharmacopeia
